Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/1995
03/14/1995US5397788 Antitumor agents, antiulcer agents, antipsychotics or anxiety
03/14/1995US5397783 Antidepressants, anxiolytic agents
03/14/1995CA1334755C Benzopyranopyridineacetic acid ester compounds and their pharmaceutical uses
03/10/1995CA2131487A1 Cessation of tobacco use
03/09/1995WO1995006727A2 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995WO1995006662A1 Neuron regulatory factor for promoting neuron survival
03/09/1995WO1995006647A1 ALKOXY-SUBSTITUTED β-CARBOLINES ACTING ON THE AMPA-RECEPTOR
03/09/1995WO1995006645A1 Benzofuran derivatives as tachykinin antagonists
03/09/1995WO1995006638A1 Tryptamine analogs with 5-ht1d selectivity
03/09/1995WO1995006637A1 Indole and indoline derivatives as 5ht1d receptor antagonists
03/09/1995WO1995006636A1 5-arylindole derivatives
03/09/1995WO1995001791A3 Use of efaxoran and its derivatives for the production of drugs for treating neurodegenerative diseases
03/09/1995CA2170901A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
03/09/1995CA2170615A1 Alkoxy-substituted .beta.-carbolines acting on the ampa-receptor
03/09/1995CA2147991A1 Tryptamine analogs with 5-ht1d selectivity
03/08/1995EP0641787A1 2H-naphth[2,3-b]-1,4-oxazine derivatives, their preparation and their use as serotonin 1D (5-HT10) receptor agonists
03/08/1995EP0641343A1 4-mercaptoacetylamino- 2] benzazepinone(3) derivatives, and use as enkephalinase inhibitors
03/08/1995EP0641330A1 Gaba and l-glutamic acid analogs for antiseizure treatment
03/08/1995EP0641328A1 Bridged aza-bicyclic derivatives as substance p antagonists
03/08/1995EP0641326A1 Substituted 1,2,3,4-tetrahydroisoquinolines with angiotensin ii receptor antagonist properties
03/08/1995EP0641320A1 New centrally acting substituted phenylazacycloalkanes
03/08/1995EP0641312A1 Synthetic aryl polyamines as excitatory amino acid neurotransmitter antagonists
03/08/1995EP0641206A1 Use of cotinine to alleviate tobacco withdrawal syndrome
03/08/1995EP0641202A1 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and parkinson's disease
03/08/1995EP0641199A1 Solid dispersion compositions of tebufelone
03/08/1995EP0641198A1 Medicaments for the treatment of anxiety
03/08/1995EP0527922B1 Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
03/08/1995EP0466769B1 Reducing post-prandial plasma large neutral amino acid concentrations
03/08/1995EP0290482B1 Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
03/08/1995CN1099759A 哌嗪衍生物 Piperazine derivatives
03/08/1995CN1099752A Novel amidoalkyl- and imidoalkyl-piperazines
03/08/1995CN1099614A 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent
03/07/1995US5395970 1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanol
03/07/1995US5395957 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds
03/07/1995US5395932 2,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
03/07/1995US5395843 Pyridones
03/07/1995US5395841 4-benzylpiperidines for treating phychosis
03/07/1995US5395835 Naphthalamides as central nervous system agents
03/07/1995CA1334669C N-substituted alkylidene-1,2,3,4-tetrahydro-9- acridinamines, a process for their preparation and their use as medicaments
03/07/1995CA1334649C Chemical splinter removal
03/07/1995CA1334648C Onset-hastened and enhanced analgesic containing ketoprofen
03/04/1995CA2117656A1 Naphthoxazines
03/02/1995WO1995006077A2 Polymeric matrices and their uses in pharmaceutical compositions
03/02/1995WO1995006044A1 Amide and urea derivatives as 5ht1d receptor antagonists
03/02/1995WO1995006040A1 Benzodiazepine compounds useful as antagonists of cck or of gastrine
03/02/1995WO1995005846A1 Neural regeneration using human bone morphogenetic proteins
03/02/1995WO1995005845A1 Pharmaceutical formulations of nerve growth factor
03/02/1995WO1995005841A1 Novel tripeptides useful in immune and cns therapy
03/02/1995WO1995005820A1 Novel use of dexmedetomidine
03/02/1995WO1995005815A1 Iontophoretic delivery of an antimigraine drug
03/02/1995WO1995005814A1 Pharmaceutical compositions comprising metal complexes
03/02/1995WO1995003303A3 Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
03/02/1995CA2170253A1 Pharmaceutical compositions comprising metal complexes
03/02/1995CA2169089A1 Benzodiazepine derivatives
03/02/1995CA2169072A1 Novel tripeptides useful in immune and cns therapy
03/02/1995CA2168449A1 Iontophoretic delivery of an antimigraine drug
03/01/1995EP0640829A2 Scanning probe microscope
03/01/1995EP0640615A1 Chelators, their preparation from the antibiotics salmycins A, B, C or D and their use
03/01/1995EP0640612A1 Novel derivatives from 2-(1H)-quinolinone, process for their preparation and pharmaceutical compositions containing them
03/01/1995EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them
03/01/1995EP0640592A1 N-acylated tricyclic azaheterorings useful as vasopressin antagonists
03/01/1995EP0640588A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them
03/01/1995EP0640099A1 Peptides having tachykinin antagonist activity
03/01/1995EP0640086A1 NOVEL MERCAPTOACETYLAMIDO PYRIDAZO 1,2]PYRIDAZINE, PYRAZOLO 1,2]PYRIDAZINE, PYRIDAZO 1,2-a] 1,2]DIAZEPINE AND PYRAZOLO 1,2-a] 1,2]DIAZEPINE DERIVATIVES USEFUL AS INHIBITORS OF ENKEPHALINASE AND ACE
03/01/1995EP0640085A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
03/01/1995EP0640084A1 6-AMINO SUBSTITUTED IMIDAZO 4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS
03/01/1995EP0640082A1 Heteroaromatic quinuclidinenes, their use and preparation
03/01/1995EP0640081A1 Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-ht antagonists
03/01/1995EP0640075A1 Certain aminomethyl phenylimidazole derivatives; a new class of dopamine receptor subtype specific ligands
03/01/1995EP0639979A1 LIGAND FOR THE c-KIT RECEPTOR AND METHODS OF USE THEREOF
03/01/1995EP0456833B1 Immunosuppressant and process for preparing the same
03/01/1995EP0406439B1 Diazabicycloalkane derivatives
03/01/1995CN1099391A Benzimidazole compounds, their use and preparation
03/01/1995CN1099386A 1,2,5,6-tetrahydropyridine derivative, process for preparing it and its applications in therapy
03/01/1995CN1099263A Ipsapirone medicament formulation
03/01/1995CN1099262A Controlled release formulation
03/01/1995CN1027759C Novel acetylcholinesterase inhibitors
03/01/1995CA2117600A1 2-(1h)-quinolinone derivatives; process for preparing the same and pharmaceutical compositions containing them
02/1995
02/28/1995US5393779 Anti-obesity, hypoglycemic, adrenergic blocking agents
02/28/1995US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them
02/28/1995US5393761 Treatment of nervous system disorders
02/28/1995US5393755 Polycyclic guanine derivatives
02/28/1995US5393747 Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists
02/23/1995WO1995005600A1 Methods of detecting and combating disorders of the central nervous system
02/23/1995WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
02/23/1995WO1995005381A1 Vasoconstrictive substituted dihydropyranopyridines
02/23/1995WO1995005379A1 Antipsychotic method
02/23/1995WO1995005366A1 Vasoconstrictive substituted aryloxyalkyl diamines
02/23/1995WO1995005364A2 Inhibitors of biogenic amine transporters
02/23/1995WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995WO1995005180A1 Methods and compositions for inhibiting uridine secretion
02/23/1995WO1995005175A1 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
02/23/1995WO1995005174A1 Antipsychotic method
02/23/1995WO1995005172A1 Methods for modulating the human sexual response
02/23/1995WO1995005169A1 Flavonoid and biflavonoid derivatives, their pharmaceutical compositions, their anxiolytic activity
02/23/1995CA2169287A1 Inhibitors of biogenic amine transporters
02/23/1995CA2169280A1 Amidine derivatives with nitric oxide synthetase activities
02/23/1995CA2169273A1 Methods of detecting and combating disorders of the central nervous system
02/22/1995EP0639573A1 Benzocondensed five membered heterocycles, process of their preparation, their use as drug, as diagnostic means and pharmaceuticals containing it
1 ... 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 ... 1833